#ACIP votes 11-0 to approve an additional dose of Pfizer-BioNTech COVID-19 vaccine (>12yo) or Moderna (>18yo) following a primary series in moderate to severe immunocompromised patients. #COVIDVaccine #TwitteRx #medtwitter
1
7
14
0
0
Download Image
Clinical considerations include: 1) 3rd dose given 28 days after primary mRNA COVID vaccine series. 2) Recommends giving at least 2 weeks before initiation of immunosuppressive therapies